Table 3 Summary of clinicopathological data from cats participating in the intravenous allogeneic cryopreserved mesenchymal stem cell (MSC) studies
Study | Stage | Creatinine (mg/dl) | Blood urea nitrogen (mg/dl) | Phosphorus (mg/dl) | Potassium (meq/l) | Packed cell volume (%) | Urine protein-to-creatinine (UPC) ratio | Urine specific gravity |
|---|---|---|---|---|---|---|---|---|
Pilot study 1 | Before | 3.5 (2.3 to 4.3) | 57 (33 to 69) | 3.8 (2.6 to 4.5) | 4.6 (3.8 to 5.5) | 31 (29 to 36) | 0.1 (0.1 to 0.2) | 1.016 (1.013 to 1.022) |
After | 3.2 (1.9 to 3.9) | 53 (36 to 58) | 3.7 (3.3 to 4.5) | 4.2 (3.9 to 4.7) | 28 (26 to 36) | 0.1 (0.1 to 0.2) | 1.016 (1.013 to 1.025) | |
Pilot study 2 | Before | 2.6 (1.9 to 3.7) | 42 (34 to 61) | 4.0 (3.6 to 4.2) | 4.6 (3.7 to 5.1) | 31 (27 to 35) | 0.1 (0.1 to 0.2) | 1.016 (1.015 to 1.030) |
After | 2.3 (1.8 to 3.9) | 37 (30 to 64) | 4.7 (2.4 to 6.7) | 4.6 (3.7 to 5.0) | 29 (27 to 34) | 0.1 (0.1 to 0.3) | 1.017 (1.013 to 1.036) | |
Pilot study 3 | Before | 2.3 (1.7 to 3.1) | 49 (34 to 53) | 4.2 (3.6 to 4.9) | 4.7 (3.9 to 5.0) | 34 (25 to 37) | 0.1 (0.1 to 0.4) | 1.017 (1.013 to 1.037) |
| Â | After | 2.5 (1.9 to 2.8) | 42 (36 to 53) | 3.8 (3.7 to 3.9) | 4.7 (4.1 to 5.0) | 33 (28 to 34) | 0.1 (0.1 to 0.4) | 1.019 (1.013 to 1.029) |